Core Viewpoint - Agilent Technologies reported a revenue of $1.67 billion for Q2 of fiscal year 2025, representing a 6% year-over-year growth, with a net profit of $373 million [1][2]. Revenue Breakdown - The Life Sciences and Diagnostics Group (LDG) generated revenue of $654 million, an 8% increase year-over-year, with a core business growth of 3% and an operating profit margin of 19.7% [4]. - The Agilent CrossLab Group (ACG) achieved revenue of $713 million, a 7% increase year-over-year, with a core business growth of 9% and an operating profit margin of 32.4% [4]. - The Applied Markets Group (AMG) reported revenue of $301 million, a 1% decline year-over-year, with core business remaining flat and an operating profit margin of 19.5% [4]. Regional Performance - Revenue in China grew by 10%, with strong performance in Asia, while the Americas saw low single-digit growth and Europe, the Middle East, and Africa experienced mid-single-digit growth [7]. - The CEO noted that all end markets achieved mid to high single-digit growth, except for a slight decline in the academic and government sectors [7]. Impact of Tariff Events - The CFO stated that the revenue for Q2 was not affected by the April tariff events, with an estimated additional tariff exposure of $5 million for the second half of the fiscal year [8][9]. - The company has implemented supply chain adjustments and cost-saving measures to mitigate the impact of tariffs, expecting to fully offset related costs by fiscal year 2026 [9].
统统都猜错!关税没影响,安捷伦Q2财报显示中国区增长10%!